Antimicrobial Activity of Zinc Oxide Nanoparticles against ESBL Producing Klebsiella pneumoniae Isolated from Equines in Egypt

被引:3
|
作者
Arafa, Amany A. [1 ]
Kandil, Mai M. [1 ]
机构
[1] Natl Res Ctr, Dept Microbiol & Immunol, Dokki, Egypt
关键词
K; pneumonia; Zinc oxide nanoparticles; Antimicrobial; Equine; Egypt; PYOGENIC LIVER-ABSCESS; ANTIBACTERIAL ACTIVITY; ZNO NANOPARTICLES; ESCHERICHIA-COLI; VIRULENCE GENES; BIOFILM; PARTICLE; STRESS; SILVER;
D O I
10.29261/pakvetj/2023.121
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Antibiotic resistance of Klebsiella pneumoniae ( K. pneumoniae ) has become alarming to public health, moreover biofilm production is one of the virulence mechanisms that contributes to antibiotic resistance. Metal oxide nanoparticles are showing promise as antibacterial agents. The purpose of this study was to assess the antibacterial activities and dosage effect of ZnO-NPs against ESBL K. pneumoniae isolates recovered from horses exhibiting respiratory symptoms. The antibiotic sensitivity of ESBL producing K. pneumoniae strains was tested using the Kirby Bauer disc diffusion method, which showed 100% resistance to cefotaxime and erythromycin while resistance to tetracycline, ampicillin, amoxicillin / clavulanic acid, ceftriaxone, ceftazidime, amikacin and ciprofloxacin were 85.7, 71.42, 42.85, 28.57, 28.57, 14.28 and14.28%, respectively. Regarding the biofilm production genes scanning, K. pneumoniae isolates were positive for luxS gene (100%), while only 85.7% of K. pneumoniae were positive for Uge gene and none of them having mrk D gene. ZnO-NPs were tested against a local isolate of ESBL-producing K. pneumoniae for their antibacterial properties. K. pneumoniae had MIC and MBC values of 5ug/ml and 3ug/ml, respectively. In the current study, antibiotic abuse leads to an increase in the population of ESBL-producing K. pneumoniae , posing a concern to public health. ZnO-NPs, a new material, exhibit significant antibacterial activity against hypermucoviscosity K. pneumoniae isolate.
引用
收藏
页码:176 / 182
页数:7
相关论文
共 50 条
  • [1] Antimicrobial activity of zinc oxide (ZnO) nanoparticle against Klebsiella pneumoniae
    Reddy, Lanka Shalini
    Nisha, Mary Magar
    Joice, Mary
    Shilpa, P. N.
    PHARMACEUTICAL BIOLOGY, 2014, 52 (11) : 1388 - 1397
  • [2] In vitro activity of three different antimicrobial agents against ESBL producing Escherichia coli and Klebsiella pneumoniae blood isolates
    Kizirgil, A
    Demirdag, K
    Ozden, M
    Bulut, Y
    Yakupogullari, Y
    Toraman, ZA
    MICROBIOLOGICAL RESEARCH, 2005, 160 (02) : 135 - 140
  • [3] In vitro antibacterial activity of ZnO and Nd doped ZnO nanoparticles against ESBL producing Escherichia coli and Klebsiella pneumoniae
    Hameed, Abdulrahman Syedahamed Haja
    Karthikeyan, Chandrasekaran
    Ahamed, Abdulazees Parveez
    Thajuddin, Nooruddin
    Alharbi, Naiyf S.
    Alharbi, Sulaiman Ali
    Ravi, Ganasan
    SCIENTIFIC REPORTS, 2016, 6
  • [4] In vitro antibacterial activity of ZnO and Nd doped ZnO nanoparticles against ESBL producing Escherichia coli and Klebsiella pneumoniae
    Abdulrahman Syedahamed Haja Hameed
    Chandrasekaran Karthikeyan
    Abdulazees Parveez Ahamed
    Nooruddin Thajuddin
    Naiyf S. Alharbi
    Sulaiman Ali Alharbi
    Ganasan Ravi
    Scientific Reports, 6
  • [5] Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae
    Lin, RD
    Chin, YP
    Lee, MH
    PHYTOTHERAPY RESEARCH, 2005, 19 (07) : 612 - 617
  • [6] Innovative Insights into In Vitro Activity of Colloidal Platinum Nanoparticles against ESBL-Producing Strains of Escherichia coli and Klebsiella pneumoniae
    Vukoja, Damir
    Vlainic, Josipa
    Ljolic Bilic, Vanja
    Martinaga, Lela
    Rezic, Iva
    Brlek Gorski, Diana
    Kosalec, Ivan
    PHARMACEUTICS, 2022, 14 (08)
  • [7] Genetic analysis of ESBL-producing Klebsiella pneumoniae isolated from UTI patients in Indonesia
    Yamasaki, Saya
    Shigemura, Katsumi
    Osawa, Kayo
    Kitagawa, Koichi
    Ishii, Aya
    Kuntaman, K.
    Shirakawa, Toshiro
    Miyara, Takayuki
    Fujisawa, Masato
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (01) : 55 - 61
  • [8] A potential antimicrobial treatment against ESBL-producing Klebsiella pneumoniae using the tellurium compound AS101
    Daniel-Hoffmann, Miriam
    Albeck, Michael
    Sredni, Benjamin
    Nitzan, Yeshayahu
    ARCHIVES OF MICROBIOLOGY, 2009, 191 (08) : 631 - 638
  • [9] A potential antimicrobial treatment against ESBL-producing Klebsiella pneumoniae using the tellurium compound AS101
    Miriam Daniel-Hoffmann
    Michael Albeck
    Benjamin Sredni
    Yeshayahu Nitzan
    Archives of Microbiology, 2009, 191 : 631 - 638
  • [10] Prevalence of ESBL genes in ESBL producing Klebsiella pneumoniae isolated from patients with urinary tract infections in Baghdad, Iraq
    Salman, Riham Adday
    Ghaima, Kais Kassim
    BIOSCIENCE RESEARCH, 2018, 15 (03): : 2049 - 2059